<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-149934</identifier>
<setSpec>1695-3703</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Outcomes of Endometrial Ablation-Resection with Monopolar Electrosurgery. Prognostic Factors Analysis</dc:title>
<dc:description xml:lang="en">Introduction: Abnormal uterine bleeding (AUB) is considered a disease with important health and social impact, as it affects a large percentage in patients of reproductive age, impairing their quality of life and assuming the leading cause of anemia and hysterectomy in women in developed countries. The treatment will depend on multiple factors, being the endometrial ablation-resection (EAR) an alternative for patients who do not wish to preserve fertility. Methods: This observational retrospective study analyze the results of hysteroscopic EAR in the Virgen de las Nieves University Hospital, and factors associated with the success or failure of the procedure. Results: We selected 260 premenopausal women who were performed hysteroscopic EAR , preceded by myomectomy  and/or polypectomy in 60,4% of patients . Follow up ranged from 1 to 79 months. Only 40 of the 260 selected patientscontinued with menorrhagia, therefore the technique was clinically successful in 84,6% of them, with amenorrhea rates of 38,5%. Moreover, 12,3% of patients needed another additional operative procedure. After 5 years of follow-up our clinic succes rate was 70,8% and 19,9% of reintervention rate. Adenomyosis was a risk factor for clinical failure and reoperation in both bivariant and multivariate analysis. When we  consider the follow-up time, adenomyosis triples risk of clinical failure and causes 5,3 fold increase in surgical failure risk. Conclusion: Hysteroscopic EAR offers favourable outcomes in patients with abnormal uterine bleeding, but when adenomyosis is suspected we must contraindicate it, or at least the patient must be informed about poor results (AU)</dc:description>
<dc:creator>Fernández Parra, Jorge</dc:creator>
<dc:creator>Romero Guadix, Bárbara</dc:creator>
<dc:creator>Aguilar Romero, Teresa</dc:creator>
<dc:creator>Rodríguez Oliver, Antonio Jesús</dc:creator>
<dc:creator>González Paredes, Aida</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: La hemorragia uterina anormal (HUA) se considera una patología con importantes repercusiones sanitarias y sociales, ya que afecta a un porcentaje elevado de pacientes en edad reproductiva, deteriorando su calidad de vida y suponiendo la principal causa de anemia e histerectomía en mujeres de países desarrollados. El tratamiento dependerá de múltiples factores, siendo la ablación-resección endometrial (ARE) una alternativa apropiada para pacientes que no desean conservar la fertilidad. Material y métodos: Estudio observacional retrospectivo que analiza los resultados de ARE histeroscópica  en el Hospital Universitario Virgen de las Nieves de Granada y los factores asociados al éxito o fracaso de la misma. Resultados: Se seleccionaron 260 pacientes premenopáusicas sometidas a ARE histeroscópica acompañada de miomectomía y/o polipectomía en el 60,4 % de los casos, con un tiempo de seguimiento entre 1 y 79 meses. De estas, solo 40 continuaron con menorragia, considerándose por tanto que la técnica resultó exitosa desde el punto de vista clínico en el 84,6 % de los casos, con tasas de amenorrea del 38,5 %, siendo necesario rentervenir al 12,3 % de las pacientes. Al analizar el éxito con el tiempo, a los 5 años de seguimiento, nuestra tasa de éxito clínico ha sido del 70,8 % y nuestra tasa de reintervención del 19,9 % (AU)</dc:description>
<dc:source>Rev. iberoam. fertil. reprod. hum;33(1): 32-38, ene.-mar. 2016. tab</dc:source>
<dc:identifier>ibc-149934</dc:identifier>
<dc:title xml:lang="es">Resultados de la Ablación-Resección Endometrial con Energía Monopolar. Análisis de Factores Pronósticos</dc:title>
<dc:subject>^d53237^s22039</dc:subject>
<dc:subject>^d30009^s22073</dc:subject>
<dc:subject>^d8764^s22012</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d28603</dc:subject>
<dc:subject>^d53237^s22045</dc:subject>
<dc:subject>^d54888^s29166</dc:subject>
<dc:subject>^d24738^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d54888^s22012</dc:subject>
<dc:subject>^d24772</dc:subject>
<dc:subject>^d55044^s22045</dc:subject>
<dc:subject>^d28380^s22045</dc:subject>
<dc:subject>^d30131^s22009</dc:subject>
<dc:subject>^d54888^s22009</dc:subject>
<dc:subject>^d14993^s22012</dc:subject>
<dc:subject>^d30131^s29166</dc:subject>
<dc:subject>^d14993^s22009</dc:subject>
<dc:type>article</dc:type>
<dc:date>201603</dc:date>
</metadata>
</record>
</ibecs-document>
